Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
Annals of Hematology
|
December 17, 2009
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)
Hyeon-Seok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, et al.
Tissue Engineering. Part C, Methods
|
October 1, 2015
Manufacture of Clinical-Grade Human Clonal Mesenchymal Stem Cell Products from Single Colony Forming Unit-Derived Colonies Based on the Subfractionation Culturing Method
TacGhee Yi, Si-na Kim, Hyun-Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 12, 2011
Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation
Seon Young Kim, Hyun Jung Min, Hyun Kyung Park, et al.
Cancer Genetics and Cytogenetics
|
July 18, 2006
Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma
Soo-Mee Bang, Young Ree Kim, Han Ik Cho, et al.
International Journal of Hematology
|
June 5, 2010
Clinical course of non-severe aplastic anemia in adults
Ji Hyun Kwon, Inho Kim, Yun Gyoo Lee, et al.
Plos One
|
November 1, 2017
Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing
Jee-Soo Lee, Heewon Seo, Kyongok Im, et al.
Annals of Hematology
|
October 19, 2010
Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia
Yun-Gyoo Lee, Inho Kim, Jin Hee Kim, et al.
Annals of Hematology
|
July 27, 2011
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Hye Jin Kim, Sung-Soo Yoon, Dong Soon Lee, et al.
Cancer Genetics and Cytogenetics
|
October 20, 2009
Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study
Miyoung Kim, Seon-Hee Yim, Nam-Sun Cho, et al.
Cancer Genetics and Cytogenetics
|
December 16, 2010
Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization
Hye Ryun Lee, Bora Oh, Dae Sik Hong, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
Annals of Hematology
|
December 17, 2009
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)
Hyeon-Seok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, et al.
Tissue Engineering. Part C, Methods
|
October 1, 2015
Manufacture of Clinical-Grade Human Clonal Mesenchymal Stem Cell Products from Single Colony Forming Unit-Derived Colonies Based on the Subfractionation Culturing Method
TacGhee Yi, Si-na Kim, Hyun-Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 12, 2011
Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation
Seon Young Kim, Hyun Jung Min, Hyun Kyung Park, et al.
Cancer Genetics and Cytogenetics
|
July 18, 2006
Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma
Soo-Mee Bang, Young Ree Kim, Han Ik Cho, et al.
International Journal of Hematology
|
June 5, 2010
Clinical course of non-severe aplastic anemia in adults
Ji Hyun Kwon, Inho Kim, Yun Gyoo Lee, et al.
Plos One
|
November 1, 2017
Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing
Jee-Soo Lee, Heewon Seo, Kyongok Im, et al.
Annals of Hematology
|
October 19, 2010
Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia
Yun-Gyoo Lee, Inho Kim, Jin Hee Kim, et al.
Annals of Hematology
|
July 27, 2011
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Hye Jin Kim, Sung-Soo Yoon, Dong Soon Lee, et al.
Cancer Genetics and Cytogenetics
|
October 20, 2009
Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study
Miyoung Kim, Seon-Hee Yim, Nam-Sun Cho, et al.
Cancer Genetics and Cytogenetics
|
December 16, 2010
Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization
Hye Ryun Lee, Bora Oh, Dae Sik Hong, et al.
Page
of 13